elacridar has been researched along with Leucocythaemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bui, T; Ho, RJ; Wu, D; Yang, Z | 1 |
Faussat, AM; Marie, JP; Simonin, G; Zhou, DC; Zittoun, R | 1 |
2 other study(ies) available for elacridar and Leucocythaemia
Article | Year |
---|---|
A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport.
Topics: Acridines; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Genotype; Haplotypes; Humans; Leukemia; Middle Aged; Paclitaxel; Polymorphism, Single Nucleotide; Tetrahydroisoquinolines; Vinblastine | 2008 |
Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells.
Topics: Acridines; Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane Permeability; Drug Resistance, Multiple; Gene Expression; Humans; Idarubicin; Isoquinolines; Leukemia; Mitoxantrone; RNA, Messenger; RNA, Neoplasm; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil | 1997 |